Xcout Intel
Cortexyme, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Cortexyme, Inc. among life sciences companies — ranked by similarity to what Cortexyme, Inc. actually does, not by market-cap band.
Subscribe to see Cortexyme, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Cortexyme, Inc.
Cortexyme, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing therapeutics for major degenerative disorders.
Cortexyme, Inc. at a glance
Cortexyme, Inc. is a life sciences company headquartered in United States. Its most recent funding round raised $84.5M in May 2018. Xcout tracks 7 named people at Cortexyme, Inc., including Dirk Thye (Chief Executive Officer, Chief Medical Officer, and Board Member).
Cortexyme, Inc. leadership
- Dirk ThyeChief Executive Officer, Chief Medical Officer, and Board Member
- Charles RyanPresident
- Brendan HannahChief Operating Officer and Chief Business Officer
- Brigette RobertsChief Corporate Affairs Officer and Board Member
- Christopher SennerChief Financial Officer, Exelixis
- June BrayPreviously SVP, Global Regulatory Affairs and Medical Writing, Allergan
1 more named person on record for Cortexyme, Inc., with roles, board committees and tenure — see the full roster →
Cortexyme, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $84.5M | — | |
| SEC Form D filing | $7.6M | — | |
| SEC Form D filing | $7.9M | — | |
| Series A | $15M | 1 named | |
| Seed | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Cortexyme, Inc. competitors
Ranked by semantic similarity — how close each company is to Cortexyme, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
Biotechnology
Cognition Therapeutics, Inc. is a public, clinical-stage biopharmaceutical company founded in 2007 and headquartered in Purchase, New York. The company develops therapies designed to protect neurons and advance treatments for patients living with age-related neurodegenerative diseases.
Biotechnology
Alzheon, Inc. is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. Founded in 2013, the company is dedicated to developing a broad portfolio of investigational therapeutic products for neurodegenerative disorders, including Alzheimer's disease. Its research centers on advancing disease-modifying treatments for patients with cognitive decline.
Biotech
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Biotech
Alzinova AB is a Swedish clinical-stage biopharmaceutical company that develops disease-modifying treatments and vaccines targeting Alzheimer's disease. Utilizing its proprietary AβCC Peptide technology, the company focuses on creating therapeutics for Alzheimer's patients to address high unmet medical needs in neurodegeneration.
Biotechnology
Spiral Therapeutics Inc. is a clinical-stage pharmaceutical company based in South San Francisco, California, focused on delivering targeted therapies for inner ear conditions.
Biotechnology
AriBio is a clinical-stage biopharmaceutical company founded in 2010 and headquartered in Seongnam, South Korea, with additional offices in the United States. The company focuses on developing novel therapeutics for neurodegenerative diseases.
Similar life sciences company
EXCIVA GmbH is a privately held biotechnology company established in 2016 in Heidelberg, Germany, focused on developing clinical-stage therapeutics to improve quality of life and treat Alzheimer's disease.
Biotechnology
Recognify Life Sciences is a clinical-stage biotechnology company located in California, focusing on developing treatments for cognitive impairment associated with central nervous system disorders.
Biotech
Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company that develops and markets cortisol modulation therapies to treat serious medical conditions. The company focuses on modulating cortisol activity at the glucocorticoid receptor to create novel treatments across therapeutic areas such as endocrinology, oncology, metabolism, and neurology.
Biotechnology
Lycia Therapeutics, Inc. is a leader in extracellular protein degradation, headquartered in South San Francisco, California.
Biotech
BioArctic AB (publ) is an innovative Swedish research-based biopharma company headquartered in Stockholm, Sweden. Incorporated in 2000, it focuses on developing disease-modifying treatments for neurodegenerative diseases. The company is publicly traded and committed to corporate governance.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Cortexyme, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Cortexyme, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →